FDA Revokes Drug Sale Licences for Cipla's Pune Facility Over Storage Violations
Quick Brief
The food and drug administration has cancelled the drug sale licences of Cipla Pharma & Life Sciences' carry and forwarding unit in Pune. Regulators discovered that pharmaceutical products were being kept directly on the floor. Additionally, authorities identified significant deficiencies in the protocols used for managing expired medicines.
What Happened?
Regulatory authorities inspected Cipla Pharma & Life Sciences' Pune carry and forwarding facility, uncovering major compliance issues. Investigators found that pharmaceutical products were stored directly on the floor and observed critical flaws in how expired medicines were handled, leading to the cancellation of the unit's drug sale licences.
Why It Matters
Storage and handling violations at major pharmaceutical distribution hubs can compromise drug safety and regulatory compliance within the supply chain.
Key Facts
- The regulatory agency cancelled the drug sale licences of Cipla Pharma & Life Sciences.
- The affected facility is a carry and forwarding unit located in Pune.
- Inspectors found medicines stored directly on the floor.
- Authorities flagged procedural deficiencies regarding the handling of expired pharmaceuticals.
Compiled from 1 outlet
Related Stories
Malabar Milma Approves ₹1.72 Crore Subsidy for Cattle Feed in Keralam
Malabar Milma has sanctioned a ₹1.72 crore subsidy aimed at supporting dairy farmers in Keralam. Through this financial backing, cattle feed will be accessible at reduced prices during September 2026. The initiative is being implemented across all primary dairy cooperative societies within the Malabar region.
Kinder Morgan Files Regulation FD Disclosure with SEC
Kinder Morgan, Inc. has submitted a Form 8-K filing to the U.S. Securities and Exchange Commission. The regulatory filing specifically addresses Item 7.01 concerning Regulation FD Disclosures. The document totals 228 kilobytes in size.
NHAI Terminates Arakkonam-Kancheepuram Builder Contract for Bengaluru-Chennai Expressway
The National Highways Authority of India (NHAI) has officially canceled the construction contract for the Arakkonam-Kancheepuram section of the Bengaluru-Chennai Expressway. To finish the remaining construction, new tenders have been issued under the engineering, procurement, and construction (EPC) mode.
RPG Life Sciences to Acquire Raghava Life Sciences' API Business for ₹135 Crore
RPG Life Sciences is moving to expand its operations by acquiring the active pharmaceutical ingredient (API) and intermediates business of Raghava Life Sciences. The transaction is valued at ₹135 crore. The purchase strengthens RPG Life Sciences' portfolio in the pharmaceutical sector.